| Relative survival (excess mortality) of individuals diagnosed with lung cancer in the PLCO Trial |
Martin Tammemagi |
Brock University / Henry Ford Health System |
PLCO |
Feb 2, 2012 |
2011-0278 |
| The association between analgesic use and risk of renal cancer |
Sara Karami |
NCI, DCEG, OEEB |
PLCO |
Feb 2, 2012 |
2011-0287 |
| Evaluation of findings in NLST false negative screens |
David Gierada |
Washington University School of Medicine |
NLST |
Dec 23, 2011 |
201112-0019 |
| Variability among NLST radiologists ? Extension to ACRIN component |
Paul Pinsky |
NCI |
NLST |
Dec 23, 2011 |
201112-0018 |
| Association of Melanoma with BMI and lifestyle risk factors |
Melody Eide |
Henry Ford Health System |
PLCO |
Dec 8, 2011 |
2010-0294 |
| The Features of Ground Glass Nodules and Part-Solid Nodules in Lung Cancer |
Deni Aberle |
University of California Los Angeles |
NLST |
Nov 29, 2011 |
201111-0044 |
| Characterizing Lung Cancers in the NLST: Imaging, Pathological, and Clinical Features |
Edward Patz, Jr. |
Duke University Medical Center |
NLST |
Nov 29, 2011 |
201111-0035 |
| Joint modeling of longitudinal and time-to-event data in NLST |
Fenghai Duan |
Brown University |
NLST |
Nov 29, 2011 |
201111-0041 |
| Analysis of Lung Cancers Detected on CXRs and Low Dose CTs in the NLST in Women Participants |
Judith Amorosa |
Cancer Institute of New Jersey |
NLST |
Nov 29, 2011 |
201111-0045 |
| Creating a resource for CAD development: Linking nodules to cancers. |
Paul Pinsky |
NCI |
NLST |
Nov 29, 2011 |
201111-0040 |
| The Outcome of Micronodules (<4mm) detected on CT in NLST participants |
Reginald Munden |
M.D. Anderson Cancer Center |
NLST |
Nov 29, 2011 |
201111-0037 |
| Diet and glioma: the Harvard Pooling Project |
Cari Kitahara |
NCI, DCEG, NEB |
PLCO |
Nov 28, 2011 |
2011-0252 |
| Insulin and Insulin-like Growth Factor Biomarkers and Prognosis of Prostate Cancer-specific Mortality |
Jing Ma |
Brigham & Women Hospital |
PLCO |
Nov 14, 2011 |
2011-0181 |
| Discrimination between Risk Profiles for Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma using Metabolomic Analysis |
Linda Liao |
NCI, DCEG, OEEB |
PLCO |
Nov 14, 2011 |
2011-0166 |
| Mucins, anti-mucin antibodies and immune complexes as risk and early detection biomarkers for ovarian cancer |
Daniel W. Cramer |
Brigham and Women's Hospital |
PLCO |
Nov 14, 2011 |
2011-0157 |
| Dietary fat, prediction of insulin-related and inflammatory biomarkers and pancreatic cancer risk |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Nov 3, 2011 |
2011-0225 |
| Feasibility of Establishing a Second Cancer Cohort Consortium |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Nov 3, 2011 |
2011-0232 |
| Risk factors for second cancers among survivors of tobacco- and alcohol-related cancers |
Meredith Shiels |
NCI, DCEG, IIB |
PLCO |
Nov 3, 2011 |
2011-0234 |
| Risk factors for second cancers among colorectal cancer survivors in a cohort consortium |
Todd Gibson |
NCI, DCEG, REB |
PLCO |
Nov 3, 2011 |
2011-0235 |
| Development and validation of a lung cancer risk prediction model |
Martin Tammemagi |
Henry Ford Health System |
NLST |
Oct 25, 2011 |
201110-0018 |
